McIlrath & Eck’s Labcorp LH Stock Holding History

McIlrath & Eck’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-58	Closed	-$12K	–	871
2022 Q2	$12K	Hold	58	–	–	﹤0.01%	476
2022 Q1	$13K	Hold	58	–	–	﹤0.01%	489
2021 Q4	$16K	Hold	58	–	–	﹤0.01%	454
2021 Q3	$14K	Hold	58	–	–	﹤0.01%	467
2021 Q2	$14K	Hold	58	–	–	﹤0.01%	464
2021 Q1	$13K	Hold	58	–	–	﹤0.01%	432
2020 Q4	$10K	Hold	58	–	–	﹤0.01%	424
2020 Q3	$9K	Hold	58	–	–	﹤0.01%	404
2020 Q2	$8K	Hold	58	–	–	﹤0.01%	395
2020 Q1	$6K	Buy	+58	New	+$8.36K	﹤0.01%	404

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

McIlrath & Eck's LH Position: Q3 2022 in Review

McIlrath & Eck sold out of Labcorp (LH) in Q3 2022, closing a stake of 58 shares — an estimated $12K sold.

McIlrath & Eck first reported a position in LH in Q1 2020 and held it in 10 quarters. The position peaked at $16K in Q4 2021. 936 funds tracked by Wall St. Rank hold LH as of Q3 2022.

McIlrath & Eck reported no remaining Labcorp position as of Q3 2022 after selling out during the quarter.
McIlrath & Eck sold 58 Labcorp shares in Q3 2022, an estimated $12K.
McIlrath & Eck first reported a position in Labcorp in Q1 2020 and held it in 10 quarters.
McIlrath & Eck's Labcorp position peaked at $16K in Q4 2021.
936 funds tracked by Wall St. Rank held Labcorp as of Q3 2022.

Based on McIlrath & Eck's 13F filing for Q3 2022, filed 18 Oct 2022.